2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- has been researched along with Hypoxia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haass, M; Hock, M; Richardt, G; Schömig, A | 1 |
1 other study(ies) available for 2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- and Hypoxia
| Article | Year |
|---|---|
Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart.
Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Calcium; Chromatography, High Pressure Liquid; Electric Stimulation; Exocytosis; Ganglia, Sympathetic; Guinea Pigs; Hypoxia; Methoxyhydroxyphenylglycol; Myocardium; Neuropeptide Y; Norepinephrine; Radioimmunoassay; Tyramine; Veratridine | 1989 |